Pharmacological and clinical evaluation of midostaurin, a multitarget tyrosine kinases inhibitorLUAN Zeng-hui, FENG Yu-fei, ZHAO Ming-yi, HU Xin615-618
Global marketing scale for anti-PD-1/PD-L1 antibody:Influence factor analysis and forecastZHOU Feng, WU Cheng619-625
An analysis of the supplementary protection certificates in the UKWANG Ying, GU Dong-lei, ZOU Tao, ZHU Ruo-lin626-633
Basic considerations on bioequivalence study of glucosamine capsulesWANG Yu, YANG Jin-bo, HE Rui-rui, LI Li, WANG Yu-zhu634-636
Preparation and evaluation of carboprost methylate hydroxypropyl-β-cyclodextrin inclusion complexHE Yao, XU Xiao-yu, CHEN Hong, XUE Qiang637-643
An improved m-hydroxyldiphenyl assay for determination of uronic acid content in Pneumococcal polysaccharideREN Zhen-yun, LIU Ai-ping, CHEN Xiao-hang, WANG Xi, LIU Qian, ZHANG Yi, ZHANG Xin-zhuang, SHEN Rong644-649
Progress in research of β-secretase inhibitors for treating Alzheimer's diseaseLI Chen-chen, LUAN Si-rui, WANG Shu-tao, LI Ning-ning, YANG Xiao-hong, GAO Li-na655-661
Kang Ai injection combined with chemotherapy in treatment of advanced non-small-cell lung cancer: a randomized,parallel controlled, multi-center studyWU Xiao-hui, ZHANG Ying, HOU Wei, LIN Li-zhu, JIANG Yi-lan, XIE Ying, SHU Qi-jin, LI Ping, WANG Shen-yu, ZHANG Hong-liang662-667